Oncology
Mechanistically intricate assays and high-throughput compound screening.
Contract Research Organization
A solution hub for accelerated drug development.
From assay design through analysis of clinical samples, our scientists run the cell-based work that moves complex therapeutic programs forward — fast, lean, and rigorous.
Cell-based assays · 96-wellEC50 · 12.4 nM
28 years of advancing science
- 28
- Years advancing discovery research
- 400+
- Human cancer cell lines
- 360+
- Cell-based assays for cytokine activity
- 30
- Recombinant cytokines in commercial production
Our expertise
Deep capability across the assay lifecycle.
01
Biomarker testing
Analytical method development and biologic-drug analysis on state-of-the-art platforms — supporting programs from discovery and preclinical work through GLP analysis of clinical samples.
Learn more02Recombinant cytokines & antibodies
Proprietary processes behind the commercial production of highly purified recombinant cytokines, monoclonal antibodies, and glycosyltransferase enzymes for the R&D market.
Learn more03Biological assays
Development and validation of cell-based assays that measure the biological activity of cytokines and growth factors, drawing on a library of disease models and assay formats.
Learn moreFrom discovery to IND
Solutions for every stage of the program.
Pick the capability you need, or talk to us about a tailored scope.
Key indications
Translational research platforms.
Disease-focused assay panels built to generate decision-grade data in the areas our partners work in.
Neurology
Cell models for neurodegeneration and neuroinflammation programs.
Kidney
Renal models supporting safety and efficacy readouts.
Metabolic
Assays for metabolic and growth-factor driven pathways.
Muscle
Models for muscle biology and regenerative targets.
About SBH
Five focused partners. One innovation hub.
SBH supports research, development, and commercialization across the life sciences — pairing a preclinical CRO with diagnostics, a bio-foundry, a startup accelerator, and a venture-building arm.
SBH Sciences
Preclinical Contract Research Organization
SBH Diagnostics
CLIA-certified, GLP-compliant biomarker analysis
SBH BioFoundry
Bridging the lab-to-market gap for early innovations
SBH BioVenture
Venture building for advanced therapeutics
Client stories
What partners say about working with us.
SBH served as our wet lab, generating accurate data with a remarkably fast turnaround at a reasonable price. I highly recommend them for start-ups looking for an efficient, cost-effective way to generate data.
Art Krieg, M.D.
Founder & CEO · Zola Therapeutics
An outstanding, cost-effective partner on our journey from concept to IND. Their team learned quickly and tackled even the most complex oncology assays, enabling us to screen thousands of compounds.
David Warshawsky, PhD
Founder & CEO · Vuja De Sciences
SBH was a cornerstone in the development of our lead program — providing lab resources that helped us reach lead optimization in record time, with top-tier science on a lean budget.
Dr. Michael Kauffman, MD, PhD
Founder · Karyopharm Therapeutics
For close to two decades we have relied on the excellent professional service SBH provides in verifying our growth factors across numerous bioassays. A great, resourceful, long-term partner.
Jon Mar Bjornsson
EVP, Research & Development · ORF Genetics
Trusted by
A few of our spotlight partners from the last decade.
Thermo Fisher
Karyopharm
ORF Genetics
Orgenesis
Renovacor
Galectin
Cullinan
University at Buffalo
Buy direct from the source — and save.
An industry source for cytokines and biologics for over 28 years. Order flagship reagents online, or scope a custom program with our scientists.